glp-1 and hot flashes receptor agonists GLP-1 Agonists in Perimenopause: Unique
Description
Healthcare system shifts Reduced burden of chronic disease: Fewer cases of type 2 diabetes, cardiovascular disease, and joint disease
Nausea, vomiting, and constipation are most common during initial weeks and dose increases, typically improving within days to weeks as the body adapts
Post-prandial glucose management: Reduction of the glycaemic impact of carbohydrate-containing meals via Reducose alpha-glucosidase inhibition
Brakenridge, S
In a randomized controlled trial assessing the effects of butyrate in obese children, there was a consistent response which showed a significant reduction of bodyweight and waist circumference compared to placebo [4]. Per-protocol analysis in the butryate group revealed a decrease in BMI of 2.26 units and a reduction in waist circumference by 5.07cm in 6 months [4]
Reviews suggest that consistent use over time is the key to experiencing the supplement's benefits
